Robin Christensen

Robin Christensen er biostatistiker ved Parker Instituttet. Han har en phd.grad i evidensbaseret reumatologi og biostatistik. 
Foruden at være senior biostatistiker på Parker Instituttet er han  ekstern lektor i medicinsk statistik ved Institut for Idræt og Biomekanik ved Syddansk Universitet. 
RC er statistisk redaktør i the Cochrane Musculoskeletal Group og i the Cochrane Public Health Group. Siden 2008 har han været med i styregruppen   for OMERACTs abejdsgruppe " Defining Flare in Rheumatoid Arthritis".  Han er i perioden 2010-2012 medlem af  redaktørgruppen for tidsskriftet Arthritis Care & Research med særligt henblik på at fremme transparent og præcis redegørelse for forskningsresultater.

Robin Christensen arbejder med et bredt felt af biostatistiske metoder.
Med vægt på klassiske statistiske metoder  står han for udformning og analyse af talrige kliniske undersøgelser og projekter på Parker Instituttet.


10 udvalgte artikler:

Bartels EM, Bliddal H, Schøndorff PK, Altman RD, Zhang W, Christensen R.
Symptomatic efficacy and safety of diacerein in the treatment of osteoarthritis:
a meta-analysis of randomized placebo-controlled trials.
Osteoarthritis and Cartilage. 2009 Oct 14. [Epub ahead of print]

Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R,
Lopez-Olivo MA, Ghogomu ET, Tugwell P.
A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview.
CMAJ. 2009 Nov 24;181(11):787-96.

Bingham III CO, Pohl C, Alten R, Christensen R, Choy EH, Hewlett SE, May JE, Strand V, Woodworth TG, Furst DE.
“Flare” and Disease Worsening in Rheumatoid Arthritis: Time for a Definition. Int J Adv Rheumatol 2009;7(3):85–91.

Bliddal H, Christensen R. The treatment and prevention of knee osteoarthritis: a tool for clinical decision-making.
Expert Opin Pharmacother. 2009 Aug;10(11):1793-804.

Maksymowych WP, Fitzgerald O, Wells GA, Gladman DD, Landewé R, Ostergaard M, Taylor WJ, Christensen R, Tak PP, Boers M, Syversen SW, Bathon JM, Ritchlin CJ, Mease PJ, Bykerk VP, Garnero P, Geusens P, El-Gabalawy H, Aletaha D, Inman RD, Kraus VB, Kvien TK, van der Heijde D.
Proposal for levels of evidence schema for validation of a soluble biomarker reflecting damage endpoints in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, and recommendations
for study design.
J Rheumatol. 2009 Aug;36(8):1792-9.

Christensen R, Lorenzen JK, Svith CR, Bartels EM, Melanson EL, Saris WH,
Tremblay A, Astrup A.
Effect of calcium from dairy and dietary supplements on
faecal fat excretion: a meta-analysis of randomized controlled trials.
Obes Rev. 2009 Jul;10(4):475-86.

Christensen R, Kristensen PK, Bartels EM, Bliddal H, Astrup A.
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials.
Lancet. 2007 Nov 17;370(9600):1706-13.

Kristensen LE, Christensen R, Bliddal H, Geborek P, Danneskiold-Samsøe B,
Saxne T.
The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review.
Scand J Rheumatol. 2007 Nov-Dec;36(6):411-7.

Christensen R, Bartels EM, Astrup A, Bliddal H.
Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis.
Ann Rheum Dis. 2007 Apr;66(4):433-9.

Qvistgaard E, Christensen R, Torp-Pedersen S, Bliddal H.
Intra-articular treatment of hip osteoarthritis: a randomized trial of hyaluronic acid, corticosteroid, and isotonic saline.
Osteoarthritis and Cartilage. 2006 Feb;14(2):163-70.